Are Syrian refugee breast cancer patients diagnosed at advanced stage and do they have treatment delays?
Future Oncol
; 19(14): 983-989, 2023 May.
Article
em En
| MEDLINE
| ID: mdl-37170860
ABSTRACT
Aim:
To compare the clinicopathological features and time to reach treatment of patients with breast cancer among Syrian refugees (SR) and Turkish citizens (TC).Methods:
Retrospective data from 2014 to 2021 were extracted from the hospital database. Student's t-test, Mann-Whitney U test and χ2 test were used to compare the two groups.Results:
Data of 88 SR and 402 TC patients were analyzed. The mean age was 45 years for SRs and 50 years for TCs. Breast cancer subtypes were similar in both groups. The de novo metastatic ratio was 23% in SRs and 21.3% in TCs and the time to reach treatment was similar between the two groups.Conclusion:
Provided the absence of any obstacle in the healthcare system, SRs are diagnosed and treated like the citizens of their host nation.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Refugiados
/
Neoplasias da Mama
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Middle aged
País como assunto:
Asia
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article